Petrova Natalia, Carassiti Daniele, Altmann Daniel R, Baker David, Schmierer Klaus
Blizard Institute (Neuroscience), Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
London School of Hygiene & Tropical Medicine, London, UK.
Brain Pathol. 2018 May;28(3):334-348. doi: 10.1111/bpa.12516. Epub 2017 May 7.
Preventing chronic disease deterioration is an unmet need in people with multiple sclerosis, where axonal loss is considered a key substrate of disability. Clinically, chronic multiple sclerosis often presents as progressive myelopathy. Spinal cord cross-sectional area (CSA) assessed using MRI predicts increasing disability and has, by inference, been proposed as an indirect index of axonal degeneration. However, the association between CSA and axonal loss, and their correlation with demyelination, have never been systematically investigated using human post mortem tissue. We extensively sampled spinal cords of seven women and six men with multiple sclerosis (mean disease duration= 29 years) and five healthy controls to quantify axonal density and its association with demyelination and CSA. 396 tissue blocks were embedded in paraffin and immuno-stained for myelin basic protein and phosphorylated neurofilaments. Measurements included total CSA, areas of (i) lateral cortico-spinal tracts, (ii) gray matter, (iii) white matter, (iv) demyelination, and the number of axons within the lateral cortico-spinal tracts. Linear mixed models were used to analyze relationships. In multiple sclerosis CSA reduction at cervical, thoracic and lumbar levels ranged between 19 and 24% with white (19-24%) and gray (17-21%) matter atrophy contributing equally across levels. Axonal density in multiple sclerosis was lower by 57-62% across all levels and affected all fibers regardless of diameter. Demyelination affected 24-48% of the gray matter, most extensively at the thoracic level, and 11-13% of the white matter, with no significant differences across levels. Disease duration was associated with reduced axonal density, however not with any area index. Significant association was detected between focal demyelination and decreased axonal density. In conclusion, over nearly 30 years multiple sclerosis reduces axonal density by 60% throughout the spinal cord. Spinal cord cross sectional area, reduced by about 20%, appears to be a poor predictor of axonal density.
预防慢性病恶化是多发性硬化症患者尚未满足的需求,其中轴突损失被认为是残疾的关键基础。临床上,慢性多发性硬化症常表现为进行性脊髓病。使用MRI评估的脊髓横截面积(CSA)可预测残疾程度的增加,因此有人提出将其作为轴突退变的间接指标。然而,CSA与轴突损失之间的关联以及它们与脱髓鞘的相关性,从未使用人类尸检组织进行过系统研究。我们对7名女性和6名男性多发性硬化症患者(平均病程 = 29年)和5名健康对照者的脊髓进行了广泛采样,以量化轴突密度及其与脱髓鞘和CSA的关联。396个组织块被嵌入石蜡中,并进行髓鞘碱性蛋白和磷酸化神经丝的免疫染色。测量包括总CSA、(i)外侧皮质脊髓束、(ii)灰质、(iii)白质、(iv)脱髓鞘区域以及外侧皮质脊髓束内的轴突数量。使用线性混合模型分析关系。在多发性硬化症中,颈、胸和腰段水平的CSA减少幅度在19%至24%之间,白质(19% - 24%)和灰质(17% - 21%)萎缩在各水平上的贡献相当。多发性硬化症患者所有水平的轴突密度降低了57% - 62%,并且影响所有纤维,无论其直径大小。脱髓鞘影响了24% - 48%的灰质(在胸段最为广泛)和11% - 13%的白质,各水平之间无显著差异。病程与轴突密度降低有关,但与任何面积指数无关。局灶性脱髓鞘与轴突密度降低之间存在显著关联。总之,在近30年的时间里,多发性硬化症使整个脊髓的轴突密度降低了60%。脊髓横截面积减少了约20%,似乎是轴突密度的一个不良预测指标。